Ayzsa Tannis

Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus–Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season — New Vaccine Surveillance Network, October 2023–February 2024

Heidi L. Moline, Ayzsa Tannis, Ariana P. Toepfer et al. · MMWR Morbidity and Mortality Weekly Report · 2024 · 174 citations · Full text

Respiratory Virus Immunity, Virus Epidemiology, Respiratory Complications +19

Risk Factors for Illness Severity Among Pregnant Women With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection—Surveillance for Emerging Threats to Mothers and Babies Network, 22 State, Local, and Territorial Health Departments, 29 March 2020–5 March 2021

Romeo R. Galang, Suzanne Newton, Kate R. Woodworth et al. · Clinical Infectious Diseases · 2021 · 115 citations · Full text

Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024

Heidi L. Moline, Ariana P. Toepfer, Ayzsa Tannis et al. · JAMA Pediatrics · 2024 · 41 citations · Full text

Substance Use Among Persons with Syphilis During Pregnancy — Arizona and Georgia, 2018–2021

Jeffrey M. Carlson, Ayzsa Tannis, Kate R. Woodworth et al. · MMWR Morbidity and Mortality Weekly Report · 2023 · 26 citations · Full text

Universal Prenatal Syphilis, Substance Use, Reproductive Epidemiology +22

Neurodevelopmental assessment of normocephalic children born to Zika virus exposed and unexposed pregnant people

Jackeline Alger, María Luisa Cafferata, Raquel López et al. · Pediatric Research · 2023 · 18 citations · Full text

Maternal Immunization, Neurodevelopmental Assessment, Early Life Exposure +12